Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5857 - 5864 of 12011 results
Massachusetts Legislature Proposes Limited Relief for Employer Medical Assistance Contribution (EMAC) Supplemental Payments
July 25, 2018| Blog| Viewpoint
Kavanaugh's Views On Arbitration Could Soon Be Tested
July 25, 2018| News
Ninth Circuit: No Ulterior Motive, No Bad Faith When Buying Claims to Block Confirmation
July 24, 2018| Blog| Viewpoint
Association Health Plan Perspectives (Part 1): Determining the Status of an AHP as “Fully-Insured”
July 24, 2018| Blog| Viewpoint
When Public Use Qualifies for the Experimental Use Exception to 35 U.S.C. § 102(b)
July 24, 2018| Blog| Viewpoint
Significant Drug Pricing Developments in July – Here’s What You Need To Know
July 24, 2018| Blog| Viewpoint
Biosimilars Action Plan Update: Public Hearing Scheduled
July 24, 2018| Blog| Viewpoint
Comcast Bows Out of Fox Bidding
July 24, 2018| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|